INHALON BIOPHARMA
Inhalon Biopharma is into developing monoclonal antibodies (mAb) using technology that enables trapping of pathogens in mucus secretions for treating diseases of the respiratory tract.
INHALON BIOPHARMA
Industry:
Biopharma Biotechnology
Founded:
2018-10-01
Address:
Carrboro, North Carolina, United States
Country:
United States
Website Url:
http://www.inhalon.com
Total Employee:
1+
Status:
Active
Contact:
607-279-1880
Total Funding:
9.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Alios BioPharma
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
CAMP4 Therapeutics
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
U.S. Army Medical Research & Development Command
U.S. Army Medical Research & Development Command investment in Grant - Inhalon Biopharma
Sand Hill Angels
Sand Hill Angels investment in Seed Round - Inhalon Biopharma
Life Science Angels
Life Science Angels investment in Seed Round - Inhalon Biopharma
Official Site Inspections
http://www.inhalon.com Semrush global rank: 5.83 M Semrush visits lastest month: 1.43 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Inhalon Biopharma"
About | Inhalon Biopharma
Inhalon Biopharma is a clinical-stage biotechnology company developing revolutionary inhaled antibody treatments for acute respiratory infections. Inhalon is rapidly advancing programs for the treatment of multiple respiratory …See details»
Home | Mucommune
Mucommune is a professional R&D organization. with a strong track record in advancing early-stage academic discoveries and inventions into IND-enabling preclinical studies and clinical …See details»
Inhalon Biopharma - Crunchbase Company Profile & Funding
Organization. Inhalon Biopharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Inhalon Biopharma is a bio-tech …See details»
Inhalon Biopharma, Inc. - Drug pipelines, Patents, Clinical trials ...
DURHAM, N.C.--(BUSINESS WIRE)-- Inhalon Biopharma (Inhalon), a clinical-stage company advancing a proprietary inhaled antibody platform for treating acute respiratory infections …See details»
Careers | Inhalon
Inhalon is a fast-growing and collaborative immunotherapy startup with a passion for developing breakthrough science to address the burden of viruses that aren’t treatable today. ... Inhalon …See details»
Inhalon Biopharma - LinkedIn
Inhalon Biopharma is developing an inhaled immunotherapy platform for treating acute respiratory infections (ARI), such as syncytial virus (RSV), influenza, metapneumovirus (MPV), parainfluenza ...See details»
Inhalon Biopharma - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Inhalon Biopharma . 1: …See details»
Inhalon Biopharma Expands Therapeutic Horizons with Licensing …
Nov 1, 2023 Inhalon Biopharma’s intellectual property includes approved U.S. and EU patents covering the composition and use of aerosolized muco-trapping antibodies. Inhalon Biopharma …See details»
Inhalon BioPharma | BIO-Europe
Inhalon’s breakthrough is a muco-trapping technology that directly binds to the virus and physically clears it from the airways. Virus trapping results in immediate reduction of viral load …See details»
Pipeline | Inhalon Biopharma
In 2002-2003, approximately 800 people died from SARS-CoV-1. In 2019, another corona virus strain, SARS-CoV-2, caused the COVID-19 pandemic. Inhalon, funded by the US Military, is …See details»
Regdanvimab: First Approval - PMC - National Center for …
Nov 1, 2021 Company Agreements. In July 2021, Inhalon Biopharma and Celltrion entered in an agreement to develop a nebulised form of regdanvimab for the treatment of COVID-19, using …See details»
Inhalon Biopharma Receives $7 Million from USAMRDC to Study …
May 26, 2021 Inhalon is supported by Breakout Labs and angel investor syndicates led by Life Science Angels and others, including, Band of Angels, Sandhill Angels, Berkeley Catalyst …See details»
Inhalon Biopharma Secures U.S. Army Medical Research and …
Nov 15, 2023 Inhalon Biopharma’s intellectual property includes approved U.S. and EU patents covering the composition and use of aerosolized muco-trapping antibodies. Inhalon Biopharma …See details»
Inhalon Biopharma Announces Positive Results from Study …
Mar 20, 2024 Inhalon Biopharma is a private, clinical-stage company advancing a proprietary inhaled antibody platform for treating a variety of acute respiratory infections.See details»
Inhalon News | January 8, 2024 - Inhalon Active
Jan 8, 2024 Inhalon Biopharma to Present on Product Development Pipeline at Biotech Showcase Durham, North Carolina, January 8, 2024 — Inhalon Biopharma, a clinical-stage …See details»
Inhalon Collaborates with Celltrion, Inc. to Develop Nebulized …
DURHAM, N.C., July 22, 2021 /PRNewswire/ -- Inhalon Biopharma, Inc., a clinical-stage immunotherapy company developing an inhaled "muco-trapping" antibody platform for treating …See details»
Inhalon News | October 7, 2021
Oct 7, 2021 Inhalon’s intellectual property includes approved U.S. and EU patents covering the composition and use of aerosolized muco-trapping antibodies. Inhalon is supported by the …See details»
Inhalon Doses First Patient in Phase 1 Study of Inhaled IN-006 to …
DURHAM, N.C., Oct. 7, 2021 /PRNewswire/ -- Inhalon Biopharma, Inc., a clinical-stage immunotherapy company developing an inhaled "muco-trapping" antibody platform for treating …See details»
Inhalon News | July 16, 2021
Jul 16, 2021 Inhalon is supported by Breakout Labs and angel investor syndicates led by Life Science Angels and others, including, Band of Angels, Sandhill Angels, Berkeley Catalyst …See details»